AM Best Wins Silver Telly Awards for ‘Our Purpose' and ‘Our Mission' Videos
The Telly Awards honor excellence in video and television across all screens and are judged by leaders from video platforms, television, streaming networks and production companies.
' Our Purpose ' illustrates the importance of AM Best's role in helping the insurance industry support the financial stability of communities, businesses and people.
' Our Mission ' traces the roots of AM Best's business priorities to its founder and his objectives in starting the company. It includes original footage taken on a period-appropriate 19 th -century passenger train to illustrate the company's journey from humble beginnings to what is now the largest credit rating agency in the world focused on the insurance industry.
To see more of AM Best's awards and recognitions, visit our page.
www.ambest.com.
Copyright © 2025 by A.M. Best Company, Inc. and/or its affiliates.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
7 hours ago
- Business Wire
CDB Aviation and Loong Air Execute Lease Agreements for Six A321neo Aircraft
HANGZHOU, China--(BUSINESS WIRE)--CDB Aviation, a wholly owned Irish subsidiary of China Development Bank Financial Leasing Co., Ltd. ('CDB Leasing'), announced the execution of new lease agreements for six Airbus A321neo aircraft with its Chinese airline customer, Zhejiang Loong Airlines Co., Ltd. ('Loong Air'). We are pleased to strengthen our partnership with Loong Air through this transaction, which underscores our commitment to supporting the growth of China's aviation sector. Share The Hangzhou-headquartered carrier is expected to take delivery of the aircraft in 2027 from the lessor's orderbook. Renowned for its fuel efficiency, reduced carbon emissions, and extended range capabilities, the A321neo, the largest member of Airbus' A320neo family, is well suited to enhance Loong Air's operational efficiency and sustainability goals. 'We are pleased to strengthen our partnership with Loong Air through this transaction, which underscores our commitment to supporting the growth of China's aviation sector,' said Jie Chen, Chief Executive Officer of CDB Aviation. 'The A321neo's superior economics and passenger comfort align perfectly with Loong Air's vision of expanding its domestic, international and regional network.' Established in 2011, Loong Air operates a fleet of over 70 Airbus A320-family aircraft, serving major Chinese cities and select international routes. The addition of the A321neos will enable the airline to boost capacity on high-demand routes while maintaining its focus on cost efficiency and environmental responsibility. 'This agreement marks another milestone in Loong Air and CDB Aviation's strategic partnership of more than 10 years,' commented Qihong Liu, Chairman of Loong Air. 'We also hope to continue to explore new opportunities of cooperation with CDB Aviation and jointly promote innovative development in the future. The A321neo's enhanced performance and cabin flexibility will allow us to offer an elevated travel experience to our passengers, while supporting our long-term sustainability objectives.' Forward-Looking Statements This press release contains certain forward-looking statements, beliefs or opinions, including with respect to CDB Aviation's business, financial condition, results of operations or plans. CDB Aviation cautions readers that no forward-looking statement is a guarantee of future performance and that actual results or other financial condition or performance measures could differ materially from those contained in the forward-looking statements. These forward-looking statements can be identified by the fact that they do not relate only to historical or current facts. Forward-looking statements sometimes use words such as 'may,' 'will,' 'seek,' 'continue,' 'aim,' 'anticipate,' 'target,' 'projected,' 'expect,' 'estimate,' 'intend,' 'plan,' 'goal,' 'believe,' 'achieve' or other terminology or words of similar meaning. These statements are based on the current beliefs and expectations of CDB Aviation's management and are subject to significant risks and uncertainties. Actual results and outcomes may differ materially from those expressed in the forward-looking statements. Accordingly, you should not rely upon forward-looking statements as a prediction of actual results and we do not assume any responsibility for the accuracy or completeness of any of these forward-looking statements. Except as required by applicable law, we do not undertake any obligation to, and will not, update any forward-looking statements, whether as a result of new information, future events or otherwise. About Loong Air Zhejiang Loong Airlines Co., Ltd. ('Loong Air') was established on April 19, 2011, with its first cargo flight launched on August 9, 2012, and its first passenger flight on December 29, 2013, Based on Hangzhou, Zhejiang Province. The company serves as Zhejiang Province's leading home-based airline and one of the key players in the aviation industry. Loong Air has established three branches in Northwest, Southwest, and Central-South of China. To date, its fleet size reach to 73, operating domestic and international passenger and cargo routes covering Mainland China, Hong Kong, Macau and extending to Japan, South Korea, Southeast Asia, South Asia, and Central Asia, transporting over 10 million passengers annually. The company is committed to four major development visions: high-quality, group operations, intelligence and international, to establish itself as a world-class aviation group. About CDB Aviation CDB Aviation is a wholly owned Irish subsidiary of China Development Bank Financial Leasing Co., Ltd. ('CDB Leasing') a 40-year-old Chinese leasing company that is backed mainly by the China Development Bank. CDB Aviation is rated Investment Grade by Moody's (A2), S&P Global (A), and Fitch (A+). China Development Bank is under the direct jurisdiction of the State Council of China and is one of the world's largest development finance institution. It is also the largest Chinese bank for foreign investment and financing cooperation, long-term lending and bond issuance, enjoying Chinese sovereign credit rating. CDB Leasing is the only leasing arm of the China Development Bank and a leading company in China's leasing industry that has been engaged in aircraft, infrastructure, ship, commercial vehicle and construction machinery leasing and enjoys a Chinese sovereign credit rating. It took an important step in July 2016 to globalize and marketize its business – listing on the Hong Kong Stock Exchange (HKEX STOCK CODE: 1606).
Business Upturn
8 hours ago
- Business Upturn
FTRE SECURITIES NEWS: Did Fortrea Holdings Inc. (NASDAQ:FTRE) Commit Securities Fraud? Contact BFA Law by August 1 Class Action Deadline
NEW YORK, July 20, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Fortrea Holdings Inc. (NASDAQ: FTRE) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Fortrea you are encouraged to obtain additional information by visiting Investors have until August 1, 2025, to ask the Court to be appointed to lead the case. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors who purchased Fortrea securities. The case is pending in the U.S. District Court for the Southern District of New York and is captioned Deslande v. Fortrea Holdings Inc., et al. , No. 1:25-cv-04630. Why was Fortrea Sued for Securities Fraud? Fortrea is a global contract research organization that provides biopharmaceutical product and medical device development solutions. In June 2023, Fortrea was spun off into a standalone, publicly traded company by Labcorp Holdings Inc. ('Labcorp'). In connection with the spin-off, Fortrea entered into several transition services agreements (the 'TSAs'), pursuant to which it agreed to pay Labcorp for certain transitional services over a set period. As alleged, Fortrea discussed the significant cost savings and margin improvements that would result from exiting the TSAs. In truth, Fortrea overstated the cost savings and margin improvement it would achieve by exiting the TSAs, as well as the amount of revenue it would generate from pre-spin projects. The Stock Declines as the Truth is Revealed On September 25, 2024, investment bank Jefferies published a report stating that the cost savings Fortrea would achieve from exiting the TSAs were '[n]ot as [m]aterial as [o]ne [m]ight [t]hink.' On this news, the price of Fortrea stock declined $2.73 per share, or over 12%, from a closing price of $22.21 per share on September 24, 2024, to $19.48 per share on September 25, 2024. Then, on March 3, 2025, Fortrea announced disappointing Q4 and full year 2024 financial results, revealing that the company's pre-spin projects 'have less revenue and less profitability than expected for 2025' and that 'post-spin work is not coming on fast enough to offset the pre-spin contract economics.' On this news, the price of Fortrea stock declined $3.47 per share, or over 25%, from a closing price of $13.85 per share on February 28, 2025, to $10.38 per share on March 3, 2025, the next trading day. Click here if you suffered losses: What Can You Do? If you invested in Fortrea you may have legal options and are encouraged to submit your information to the firm. All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses. Submit your information by visiting: Or contact:Ross Shikowitz [email protected] 212-789-3619
Business Upturn
8 hours ago
- Business Upturn
HIMS SECURITIES NEWS: Did Hims & Hers Health, Inc. (NYSE:HIMS) Commit Securities Fraud? Contact BFA Law by August 25 Class Action Deadline
NEW YORK, July 20, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Hims & Hers Health, Inc. (NYSE: HIMS) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Hims & Hers, you are encouraged to obtain additional information by visiting: Investors have until August 25, 2025, to ask the Court to be appointed to lead the case. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors who purchased Hims & Hers securities. The case is pending in the U.S. District Court for the Northern District of California and is captioned Sookdeo v. Hims & Hers Health, Inc., et al. , No. 25-cv-05315. A subsequent complaint alleging substantially similar claims was also filed and is captioned Yaghsizian v. Hims & Hers Health, Inc., et al. , No. 25-cv-05321. Why was Hims & Hers Sued for Securities Fraud? Hims & Hers operates a telehealth platform that provides consumers with access to online consultations with licensed healthcare professionals, prescription medications, and a range of wellness products. On April 29, 2025, Hims & Hers and Novo Nordisk announced a 'long-term collaboration' starting with the immediate sale of Novo Nordisk's popular weight loss drug Wegovy on the Hims & Hers platform. The active ingredient in Wegovy is semaglutide. As alleged, Hims & Hers touted and misrepresented to investors the nature of its partnership with Novo Nordisk, including asserting that under the terms of the agreement His & Hers could offer both Wegovy and compounded semaglutide to its customers. Hims & Hers also allegedly represented to investors that its sale of compounded semaglutide complied with FDA regulations. The Stock Declines as the Truth is Revealed On June 23, 2025, Novo Nordisk announced that it was terminating the partnership, 'based on Hims & Hers deceptive promotion and selling of illegitimate, knockoff versions of Wegovy that put patient safety at risk' and alleged that Hims & Hers 'failed to adhere to the law which prohibits mass sales of compounded drugs.' On this news, the price of Hims & Hers stock fell $22.24 per share, or more than 34%, from $64.22 per share on June 20, 2025 to $41.98 per share on June 23, 2025. Click here for more information: What Can You Do? If you invested in Hims & Hers you may have legal options and are encouraged to submit your information to the firm. All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses. Submit your information by visiting: Or contact:Ross Shikowitz [email protected] 212-789-3619
